
Randomization and unblinding
Master the investigator's responsibilities for maintaining randomization integrity, protecting blinding throughout trial conduct, and executing emergency unblinding procedures when participant safety requires it.
Randomization and unblinding
At 2:47 AM, the on-call physician at a Phase III trial site receives an urgent page. A participant has arrived at the emergency department with severe respiratory distress. The treating physician needs to know immediately: Is this participant on the active treatment or placebo? The answer will guide critical decisions about potential drug interactions and treatment approaches. Somewhere in the site's files is a sealed envelope that contains this information. But should it be opened?